Re: Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia
Bensink, Mark, Edwards, Christine, Bowers, Charles, Campbell, JonLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2018.1452747
Date:
March, 2018
File:
PDF, 582 KB
english, 2018